TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0100
0.00 (0.00%)
At close: Nov 6, 2026
TrivarX Company Description
TrivarX Limited, a biotechnology company, engages in the development of AI-driven, and scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
It is also involved in research, development, and commercialisation of diagnostic and pharmaceutical products.
The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023.
TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.
TrivarX Limited
| Country | Australia |
| Founded | 1987 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Danielle Meyrick |
Contact Details
Address: Suite 1.01 Hawthorn East, VIC 3123 Australia | |
| Phone | 61 3 8319 0962 |
| Website | trivarx.com |
Stock Details
| Ticker Symbol | TRI |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000MEB8 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Dr. Danielle Meyrick M.D., Ph.D. | Chief Executive Officer |
| Kai Sun | Chief Operating Officer |
| Dr. Anthony James Keating | Executive Director |
| Josh Purdy | Public Relations Director |
| Massimiliano Grassi | Head of Artificial Intelligence |
| Cameron Peter Jones C.A. | Joint Company Secretary |
| Nova Anne Taylor | Joint Company Secretary |